Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

24 Apr 2008 11:33

UBS AG (EPT)24 April 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 23 APRIL 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 492,250 0.45% 1,214 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 492,250 0.45% 1,214 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) PURCHASE 30 1502 pence PURCHASE 94 1502 PURCHASE 260 1502 PURCHASE 372 1502 PURCHASE 701 1502 PURCHASE 141 1503 SALE 300 1504 SALE 126 1504 SALE 1400 1505 SALE 600 1505 SALE 40 1505 PURCHASE 120 1505 PURCHASE 583 1505 PURCHASE 1500 1505 SALE 978 1506 SALE 825 1506 SALE 500 1506 SALE 364 1506 SALE 220 1506 SALE 215 1506 SALE 100 1506 PURCHASE 137 1506 PURCHASE 200 1506 PURCHASE 261 1506 PURCHASE 666 1506 PURCHASE 770 1506 PURCHASE 608 1507 PURCHASE 609 1507 SALE 185 1508 PURCHASE 306 1508 SALE 200 1509 SALE 142 1509 SALE 1376 1510 SALE 30 1510 PURCHASE 138 1510 PURCHASE 1310 1513 PURCHASE 376 1515 SALE 256 1517 SALE 1032 1518 SALE 984 1518 SALE 495 1518 PURCHASE 393 1518 SALE 529 1519 SALE 275 1519 PURCHASE 738 1519 PURCHASE 64 1520 TOTAL PURCHASES 10,377 TOTAL SALES 11,172 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 24 APRIL 2008Contact name LOUISE ROBINSONTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM
16th May 20224:11 pmRNSNotice of AGM, Posting of Annual Report & Accounts
7th Apr 20224:40 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSEngage and Victory XR to Launch 10 Metaversities
28th Mar 20227:00 amRNSNew Senior Appointments to help drive US Growth
8th Mar 20227:01 amRNSFinal Results
4th Mar 202211:30 amRNSAIM Rule 17 Schedule 2(g) Update
16th Feb 20227:00 amRNSNotice of Results & Investor Presentation
31st Jan 20227:00 amRNSPre-Close Trading Update & Directorate Change
23rd Nov 20217:00 amRNSDirectorate Changes
12th Nov 20217:00 amRNSENGAGE Update & Investor Presentation
5th Nov 202110:24 amRNSExercise of Options
1st Jul 20081:02 pmRNSDirector Dealings
1st Jul 200811:16 amRNSScheme Effective
30th Jun 20085:52 pmRNSHolding(s) in Company
30th Jun 20083:03 pmRNSRule 8.3- Expro International
30th Jun 20082:19 pmBUSRule 8.3 - Expro International
30th Jun 200812:52 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:42 pmRNSEPT Disclosure - Expro Intl G
30th Jun 200812:37 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:11 pmRNSRule 8.3- Expro International
30th Jun 200811:16 amRNSHolding(s) in Company
30th Jun 200811:03 amRNSScheme of arrangement
27th Jun 20085:01 pmRNSRule 2.10 Announcement
27th Jun 20085:00 pmRNSSuspension - Expro Internatio
27th Jun 20084:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.